Rayner Achieves Milestone Implantations in Landmark Clinical Trials in China and the USA
Posted on 11/08/2023
Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology